Recall: D-0507-2026

Class II - Potentially Harmful

Class IIClassification

2026-04-01Initiated

OngoingStatus

Wells Pharma of Houston LLCFirm

Product

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.

Reason

cGMP deviations.

Distribution

U.S. Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.